European Archives - Page 632 of 1078 - European Medical Journal

ICDS 2020 Interview: Doctor Ron G. Landmann

Doctor Ron G. Landmann | Executive Council for the US Commission on Cancer National Accreditation Program for Rectal Cancer…

ICDS 2020 Interview: Doctor Miklosh Bala

Doctor Miklosh Bala | Department of Surgery, Director of Trauma, Hadassah Medical Centre, Jerusalem, Israel…

ICDS 2020 Interview: Professor Steven D. Wexner

Professor Steven D. Wexner | Director of the Digestive Disease Center, Cleveland Clinic Florida, Weston, Florida, USA…

First national study to reveal impact of COVID-19 pandemic on the mental health and wellbeing of NHS and non-NHS health workers

First national study to reveal impact of COVID-19 pandemic on the mental health and wellbeing of NHS and non-NHS health workers

A nationwide study to investigate the psychological impact of the COVID-19 pandemic on health workers in the NHS, care and nursing homes…

Yann Le Cam CEO of EURORDIS-Rare Diseases Europe

What motivated you to dedicate your career to raising awareness of rare diseases? My eldest daughter is living with cystic fibrosis. I have experienced….

Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry

Initial Results of the COVID-19 Global Rheumatology Alliance Provider Registry

COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of particular concern to patients who are immunocompromised…

NRAS: 'Being Diagnosed with Rheumatoid Arthritis'

New Evidence Linking Gout and Risk of Heart Failure

GOUT has been linked to increased risk of incident heart failure in older adults according to a recent study by Dr Lisandro Colantonio and colleagues…

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

EMJ Hematology 8 [Suppl 2] 2020

Diffuse large B-cell lymphoma (DLBCL) was considered an incurable disease until the introduction of polychemotherapy…

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

Antibody Therapies for Patients With Diffuse Large B-cell Lymphoma: What Does the Future Hold?

Prof Sehn opened the symposium with an overview of diffuse large B-cell lymphoma (DLBCL) focussing on key milestones in treatment developments…

Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation

Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation

ARTIFICIAL intelligence could be used as a crucial tool for clear, objective assessment of lung disease to aid radiologists in what has been a measured…